Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients

National Consumers League

Smith, 1999, Nonprescription and alternative medication use by individuals with HIV disease, Ann Pharmacother, 33, 294, 10.1345/aph.18320

Nykamp, 1997, Cost of medication therapy in ambulatory HIV-infected patients, Ann Pharmacother, 31, 303, 10.1177/106002809703100306

Furler, 2004, Polypharmacy in HIV: impact of data source and gender on reported drug utilization, AIDS Patient Care STDS, 18, 568, 10.1089/apc.2004.18.568

Clark, 2001, Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports, BMJ, 323, 706, 10.1136/bmj.323.7315.706

Biskupiak, 2006, Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs, J Pain Palliat Care Pharmacother, 20, 7, 10.1080/J354v20n03_03

Dajani, 1998, Gastrointestinal toxicity of over-the-counter analgesics, Am J Gastroenterol, 93, 1020, 10.1111/j.1572-0241.1998.01020.x

Farquhar, 1999, Effects of acetaminophen and ibuprofen on renal function in the stressed kidney, J Appl Physiol, 86, 598, 10.1152/jappl.1999.86.2.598

Fored, 2001, Acetaminophen, aspirin, and chronic renal failure, N Engl J Med, 345, 1801, 10.1056/NEJMoa010323

Perneger, 1994, Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs, N Engl J Med, 331, 1675, 10.1056/NEJM199412223312502

Bolesta, 2002, Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors, Ann Pharmacother, 36, 331, 10.1345/aph.1A035

Watkins, 2006, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial, JAMA, 296, 87, 10.1001/jama.296.1.87

Nebeker, 2004, Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting, Ann Intern Med, 140, 795, 10.7326/0003-4819-140-10-200405180-00017

Von Bargen, 1998, How many pills do patients with HIV infection take?, JAMA, 280, 29, 10.1001/jama.280.1.29

Fulco, 2006, Acid suppressive therapy and the effects on protease inhibitors, Ann Pharmacother, 40, 1974, 10.1345/aph.1H022

Lunzen, 2007, Concomitant use of gastric acid-reducing agents is frequent among HIV-infected patients receiving protease inhibitor-based highly active antiretroviral therapy, HIV Med, 8, 220, 10.1111/j.1468-1293.2007.00456.x

Covington, 1999

Pray, 1999

Chan, 2006, Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events, Circulation, 113, 1578, 10.1161/CIRCULATIONAHA.105.595793

Sorensen, 2000, Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin, Am J Gastroenterol, 95, 2218, 10.1111/j.1572-0241.2000.02248.x

Curhan, 2004, Lifetime nonnarcotic analgesic use and decline in renal function in women, Arch Intern Med, 164, 1519, 10.1001/archinte.164.14.1519

Max, 2000, Management of the adverse effects of antiretroviral therapy and medication adherance, Clin Infect Dis, 30, S96, 10.1086/313859

Caranasos, 1974, Drug-induced illness leading to hospitalization, JAMA, 228, 713, 10.1001/jama.1974.03230310023021

Ives, 1987, Drug-related admissions to a family medicine inpatient service, Arch Intern Med, 147, 1117, 10.1001/archinte.1987.00370060113019

Food and Drug Administration, Department of Health and Human Services. Over-the-counter human drugs: labeling requirements, final rule. Fed Regist 13254–13303. Available at: http://www.fda.gov/cder/otc/label/label-frreg.htm. Accessed 05.20.07.

Covington, 2006, Nonprescription medications and self-care. Nonprescription drug therapy: issues and opportunities, Am J Pharm Educ, 70, 10.5688/aj7006137

Bond, 2003, Issues related to monitoring the safety of over-the-counter (OTC) medicines, Drug Saf, 26, 1065, 10.2165/00002018-200326150-00001

Consumer Healthcare Products Association (CHPA)